SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLife Settlemen Regulatory News (LSAA)

Share Price Information for Life Settlemen (LSAA)

Share Price is delayed by 15 minutes
Get Live Data
1.795    0.00 (0.00%)
Bid:
1.77
Ask:
1.82
Spread: 0.05 (2.825%)
Market Cap: $75.42m
LSAA Live PriceLast checked at - London Stock Exchange

Intraday Life Settlemen Share Chart

Half-year Report

20 Sep 2024 07:00

RNS Number : 9405E
Life Settlement Assets PLC
20 September 2024
 

Life Settlement Assets PLC: Final Results

20 September 2024

 

Life Settlement Assets PLC

(the "Company" or "LSA")

 

Results for the Half Year ended 30 June 2024

 

LSA, a closed-ended investment trust company which invests in, and manages, portfolios of whole interests in life settlement policies issued by life insurance companies operating predominantly in the United States, is pleased to announce its results for the Half Year ended 30 June 2024.

 

The highlights of the year were as follows:

 

Net Asset Value

· USD 108.8 million, representing USD 2.26 per share.

 

Maturities

· Maturities totalling USD 15.7 million were declared - of these, USD 11.8 million were non-HIV policies, and USD 3.9 million were HIV policies.

 

Mutual Benefits Keep Policy Trust ("MBC") Action

· Portfolio structure simplified following the MBC acquisition, and the Company is now in the final stages of absorbing this acquisition. 

 

Costs

· Ongoing charges ratio excluding policy servicing fees and legal costs of 3.2% of NAV.

· Ongoing focus on management of costs.

 

Dividends

· On 15 February 2024 LSA announced the declaration of a special dividend of 6.0209 cents per share, totalling approximately USD 3.0 million, which was paid to Shareholders on 15 March 2024.

 

Share buybacks

· Total of 1,685,069 shares bought back and cancelled in the period at a total cost of USD 2,954,943. 

 

Post Balance Sheet Events

The Company has bought back and cancelled a further 1,699,801 shares at a total cost of USD 3,044,701 since the period end and at the date of this report there were 46,441,914 shares in issue.

 

On 28 August 2024 the Company received notification that funds amounting to USD 9.7 million had been received by the Company, comprising the first tranche of the MBC sale proceeds of USD 5.7 million and the return of overpaid premiums of USD 4.0 million. The impact of this refund was reflected in the 31 July 2024 Net Asset Value of USD 2.3338 released to the market on 16 September 2024.

 

Michael Baines, Chairman, commented:

The Board remains focused on monitoring the performance of the Company's policy portfolio, accurately assessing mortality risk, and actively managing its cost base against the background of inflationary pressures. These results demonstrate further progress in the execution of the Board's strategy, which will allow further consideration of additional opportunities to return value to Shareholders.

 

The Directors are pleased to attach the Company's results for the Half Year ended 30 June 2024.

 

Click on the following link, or paste it into your web browser, to view the associated PDF document:

 

http://www.rns-pdf.londonstockexchange.com/rns/9405E_1-2024-9-19.pdf

 

The results for the half year ended 30 June 2024 may also be downloaded from the Company's website at

https://www.lsaplc.com/investor-relations/annual-reports/

 

 

For further information contact:

 

Acheron Capital Limited (Investment Manager)

Jean-Michel Paul

020 7258 5990

 

Shore Capital (Financial Adviser and Broker)

Anita Ghanekar/Gillian Martin /Harry Davies-Ball

020 7408 4090

 

ISCA Administration Services Limited

Company Secretary

Tel: 01392 487056

 

DISCLAIMER

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

 

Notes to Editors

Life Settlement Assets PLC is a closed-ended investment trust company which invests in, and manages, portfolios of whole interests in life settlement policies issued by life insurance companies operating predominantly in the United States. The Company seeks to generate long-term returns for investors by investing in the life settlement market. The Company aims to manage its investment in portfolios of life settlement products so that the realised value of the policy maturities exceeds the aggregate cost of acquiring the policies, ongoing premiums, management fees and other operational costs.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR UKRNRSSUKAAR
Date   Source Headline
9th Jun 20266:13 pmRNSResult of AGM
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20262:56 pmRNSNet Asset Value(s)
1st Jun 20269:21 amRNSTotal Voting Rights
26th May 20269:08 amRNSTransaction in Own Shares
18th May 20269:11 amRNSTransaction in Own Shares
12th May 20268:06 amRNSTransaction in Own Shares
11th May 20267:25 amRNSTransaction in Own Shares
7th May 20266:10 pmRNSTransaction in Own Shares
7th May 20268:23 amRNSTransaction in Own Shares
6th May 20261:50 pmRNSNet Asset Value(s)
5th May 20268:54 amRNSTransaction in Own Shares
1st May 20263:30 pmRNSTotal Voting Rights
28th Apr 20265:42 pmRNSTransaction in Own Shares
28th Apr 20267:00 amRNSFinal Results
22nd Apr 20268:13 amRNSTransaction in Own Shares
13th Apr 20261:42 pmRNSNet Asset Value(s)
1st Apr 20268:19 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSNet Asset Value(s)
20th Mar 202611:20 amRNSTransaction in Own Shares
19th Mar 20268:52 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSShare Buyback Programme
16th Mar 20267:00 amRNSShare Buyback Programme
9th Mar 20267:02 amRNSNet Asset Value(s)
9th Mar 20267:00 amRNSPortfolio Update
7th Jan 20265:46 pmRNSNet Asset Value(s)
18th Dec 20255:46 pmRNSNet Asset Value(s)
27th Nov 20257:00 amRNSAppointment of Corporate Broker
11th Nov 20252:23 pmRNSNet Asset Value(s)
7th Oct 20251:57 pmRNSNet Asset Value(s)
29th Sep 20257:00 amRNSResults for the Half Year ended 30 June 2025
29th Aug 20251:00 pmRNSNet Asset Value(s)
31st Jul 20259:50 amRNSNet Asset Value(s)
4th Jul 20254:06 pmRNSNet Asset Value(s)
1st Jul 20259:33 amRNSTotal Voting Rights
26th Jun 20255:32 pmRNSDirector Declaration
25th Jun 20257:00 amRNSPortfolio Update
18th Jun 20252:47 pmRNSAGM Statement
18th Jun 202511:23 amRNSNet Asset Value(s)
13th Jun 20257:00 amRNSTransaction in Own Shares
12th Jun 20257:00 amRNSTransaction in Own Shares
2nd Jun 202511:55 amRNSNet Asset Value(s)
2nd Jun 202510:51 amRNSTotal Voting Rights
2nd Jun 20257:00 amRNSTransaction in Own Shares
1st May 202512:21 pmRNSNet Asset Value(s)
1st May 202512:12 pmRNSNet Asset Value(s)
1st May 20259:23 amRNSTotal Voting Rights
29th Apr 20257:00 amRNSFinal Results
9th Apr 20257:00 amRNSTransaction in Own Shares
8th Apr 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.